Pathogenesis and therapeutic interventions for ANCA-associated vasculitis

Overview of attention for article published in Nature Reviews Rheumatology, December 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 1 news outlet
twitter: 71 X users
patent: 2 patents

facebook: 4 Facebook pages
wikipedia: 5 Wikipedia pages

Citations

dimensions_citation: 313 Dimensions

Readers on

mendeley: 317 Mendeley

Summary News X Patents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

CLOZAPINE FOR USE IN TREATING PATHOGENIC IMMUNOGLOBULIN DRIVEN B CELL DISEASE

Application WO-2021019249-A1

World Intellectual Property Organisation (WIPO)

CLOZAPINE FOR THE TREATMENT OF IG-E DRIVEN B CELL DISEASES

Application WO-2019149863-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.